PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)

CUSIP: 69366J200

Q4 2016 13F Holders as of 31 Dec 2016

Holder snapshot 7 signals
Share change
-1,072,991
Put/Call ratio
52%
SEC-reported price per share
$10.91
Number of holders
117
Value change
-$24,470,762
Number of buys
54
Open additional details 1 more signal available
Number of sells
66
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
81,782,297

Security key

69366J200

Report period

Q4 2016

Institutions

117

Top holders

10

Ownership snapshot

Top reported holders of PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
30 Sep 2016
13F Lead comparable stake: 5.7% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 5.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 5.7%
Camber Capital Management LP 2.4%
VANGUARD GROUP INC 2.3%
BlackRock Fund Advisors 1.7%
BB BIOTECH AG 1.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
5.7%
$65,123,000
4,648,386 shares
30 Sep 2016
Camber Capital Management LP
13F
Company
13F
2.4%
$28,020,000
2,000,000 shares
30 Sep 2016
VANGUARD GROUP INC
13F
Company
13F
2.3%
$25,911,000
1,849,447 shares
30 Sep 2016
BlackRock Fund Advisors
13F
Company
13F
1.7%
$19,398,000
1,384,550 shares
30 Sep 2016
BB BIOTECH AG
13F
Company
13F
1.4%
$16,573,000
1,182,912 shares
30 Sep 2016
TOCQUEVILLE ASSET MANAGEMENT L.P.
13F
Company
13F
1.4%
$16,458,000
1,174,730 shares
30 Sep 2016
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2016

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
117
Shares
28,676,672
Rows available
117
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders
110
Q4 2016 holders
117
Holder diff
7
Investor Q3 2016 Shares Q4 2016 Shares Share Diff Share Chg % Q3 2016 value Q4 2016 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .